As part of our ongoing aim to bring you reports of innovative developments, we have added a review of a recent study titled: Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort.
Independent commentary is provided by Associate Professor Andrew Östör, a Consultant Rheumatologist at Cabrini Medical Centre and an Associate Professor at Monash University, Melbourne.
Please login below to download this issue (PDF)